These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1112985)

  • 1. Antibody-dependent cytotoxicity: modulation by the cytochalasins and microtubule-disruptive agents.
    Gelfand EW; Morris SA; Resch K
    J Immunol; 1975 Mar; 114(3):919-24. PubMed ID: 1112985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of macrophage C3b receptor function by cytochalasin-sensitive structures.
    Atkinson JP; Michael JM; Chaplin H; Parker CW
    J Immunol; 1977 Apr; 118(4):1292-9. PubMed ID: 557509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of human cell-mediated cytotoxicity. III. Dependence of natural killing on microtubule and microfilament integrity.
    Katz P; Zaytoun AM; Lee JH
    J Immunol; 1982 Dec; 129(6):2816-25. PubMed ID: 6890568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-mediated target cell lysis by non-immune cells. Characterization of the antibody and effector cell populations.
    Gelfand EW; Resch K; Prester M
    Eur J Immunol; 1972 Oct; 2(5):419-24. PubMed ID: 5084393
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of microtubule- and microfilament-disrupting drugs on preimplantation mouse embryos.
    Siracusa G; Whittingham DG; De Felici M
    J Embryol Exp Morphol; 1980 Dec; 60():71-82. PubMed ID: 7198136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-mediated target cell lysis by nonimmune cells: the use of anti-immunoglobulin to distinguish effector cell population.
    Resch K; Gelfand EW; Prester M
    J Immunol; 1974 Feb; 112(2):792-803. PubMed ID: 4544363
    [No Abstract]   [Full Text] [Related]  

  • 7. Human monocyte-mediated lysis of antibody-coated tumor cells: the role of the cytoskeleton in monocytes.
    Espevik T
    J Immunol; 1985 Mar; 134(3):2017-25. PubMed ID: 3881531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-dependent cell-mediated cytotoxicity. II. Early interactions between effector and target cells.
    Scornik JC
    J Immunol; 1974 Nov; 113(5):1519-26. PubMed ID: 4418199
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro effects of colchicine and vinblastine on the secretory process of antibody-producing cells.
    Antoine JC; Maurice M; Feldmann G; Avrameas S
    J Immunol; 1980 Nov; 125(5):1939-49. PubMed ID: 7191865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microtubule--and microfilament--disrupting drugs and melanosome migration in melanophores of Papiliochromis ramirezi (Cichlidae, Teleostei).
    Visconti MA; Castrucci AM
    An Acad Bras Cienc; 1985 Jun; 57(2):233-7. PubMed ID: 4096435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-dependent lymphoid cell-mediated cytotoxicity: role of complement.
    Van Boxel JA; Paul WE; Green I; Frank MM
    J Immunol; 1974 Jan; 112(1):398-403. PubMed ID: 4812178
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytotoxic immune cells with specificity for defined soluble antigens. V. Interaction of antibody with the cytotoxic effector cells in immune or non-immune mouse spleen cells.
    Schirrmacher V; Rubin B; Pross H
    J Immunol; 1974 Jun; 112(6):2219-26. PubMed ID: 4856907
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody-dependent cell-mediated cytotoxicity. III. Two functionally different effector cells.
    Scornik JC; Cosenza H
    J Immunol; 1974 Nov; 113(5):1527-32. PubMed ID: 4213695
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of liposome treatment and cytoskeleton-inhibiting drugs on the capping kinetics of rabbit T lymphocytes at various stages of differentiation.
    Roozemond RC; Roholl PJ
    Eur J Cell Biol; 1984 Nov; 35(2):322-6. PubMed ID: 6335087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cytoskeletal disrupting agents on replication of bovine endothelium.
    Selden SC; Rabinovitch PS; Schwartz SM
    J Cell Physiol; 1981 Aug; 108(2):195-211. PubMed ID: 7263771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microtubule inhibitors differentially affect translational movement, cell surface expression, and endocytosis of transferrin receptors in K562 cells.
    Thatte HS; Bridges KR; Golan DE
    J Cell Physiol; 1994 Aug; 160(2):345-57. PubMed ID: 7913709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cytochalasins B and D and colchicine on migration of the corneal epithelium.
    Gipson IK; Westcott MJ; Brooksby NG
    Invest Ophthalmol Vis Sci; 1982 May; 22(5):633-42. PubMed ID: 7200475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-dependent cell-mediated cytotoxicity in humans. I. Characterization of the effector cell.
    Trinchieri G; Bauman P; De Marchi M; Tökés Z
    J Immunol; 1975 Jul; 115(1):249-55. PubMed ID: 125298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the antibody-dependent cytotoxic cell. A non-phagocytic monocyte?
    Greenberg AH; Shen L; Roitt IM
    Clin Exp Immunol; 1973 Oct; 15(2):251-9. PubMed ID: 4762018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.